Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Statistics in 5 minutes

The controlled-randomized study: the queen among studies

    • Education
    • General Internal Medicine
    • Prevention and health care
    • RX
    • Studies
  • 3 minute read

It is considered the gold standard among studies, the queen against which all other studies must be measured: The controlled-randomized study. It is used whenever evidence of the efficacy and safety of a new therapy is needed. Therefore, it also serves as the basis for approval decisions.

Without clinical research, there would be no progress in medicine. It is a prerequisite for providing evidence-based treatment. Until that happens, many experimental approaches must be pursued, discarded, and rebuilt. But at some point, the time has come when the efficacy and safety of the therapy can and must be examined more closely. At this point, the controlled-randomized trial (RCT; “randomised controlled trials”) comes into play. It is considered the gold standard among investigational methods because they generally have a low risk of systematic error and, along with meta-analyses, are characterized by the highest level of evidence.

Study design for experimental studies

RCTs are interventional studies that demonstrate the superiority of a new therapy compared with a standard therapy or a sham therapy (placebo). The basis of every RCT is a study protocol that specifies, among other things, the medical-scientific background, the benefit-risk assessment, the study design, the study methodology, and the entire planning, conduct, and evaluation. A primary objective criterion is defined that aims to answer the main research question. For example, if the superiority of a new therapy is to be demonstrated, a null hypothesis is first assumed. This assumes that there is no difference in efficacy between the therapies studied. During the evaluation, statistical tests are then used to decide whether the assumed null hypothesis holds or must be rejected. In addition, secondary objectives that capture other effects of treatment such as adverse events will be investigated.

Case number planning is an indispensable parameter to achieve statistical power of the study. It is based on the number of participants necessary to detect a minimally relevant difference in the effectiveness of the therapies from a clinical point of view with a high probability of being significant – if it exists. A study population with clear inclusion and exclusion criteria is then defined for the study design. This ensures homogeneity of the group in terms of demographic characteristics, disease state, and concomitant diseases and medications, if any. This is the only way to ensure comparability between the different groups.

Randomization determines the allocation of patients to each treatment group. This is done randomly. This is because the aim is to ensure that all potential confounding variables are equally distributed in all groups. Confounding variables include weight, age, or gender – characteristics that could influence treatment response. Furthermore, the blinding of the study helps to avoid systematic errors. It is possible to double-blind or single-blind a study. In a double-blind study, neither the patient nor the investigator knows which treatment the patient has been randomized to. In simple blinding, usually only the patient is blinded as to the assigned treatment.

Evaluation of the causal relationship between therapy and efficacy

Clinical trials are generally subject to national and international scientific and ethical requirements. In 1964, the World Medical Association formulated ethical principles for research involving human subjects in the Declaration of Helsinki, which has since been revised several times. When publishing an RCT, the study design, conduct, and analysis must be described in a comprehensible manner. Against the background of the study design, current literature and taking into account the state of the art, the study results and their interpretation are to be discussed in detail in the study report and in a publication, and existing methodological limitations are to be presented. Critical discussion is a key contributor to the clinical evaluation of the results.

Nevertheless, the gold standard is repeatedly questioned because RCTs are an ideal instrument to answer the question of a causal relationship between therapy and efficacy. But the clinical care reality is insufficiently represented. Experts therefore expect RCTs to remain the standard for approval decisions, but to be supplemented by additional data from real-world studies, for example.

 

Further reading:

  • www.thieme-connect.com/products/ejournals/pdf/10.1055/s-0030-1253250.pdf
  • www.aerzteblatt.de/archiv/106949/Randomisierte-kontrollierte-Studien
  • https://flexikon.doccheck.com/de/Randomisierte_kontrollierte_Studie

 

InFo ONCOLOGY & HEMATOLOGY 2022; 10(2): 32.

Autoren
  • Leoni Burggraf
Publikation
  • InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
  • Admission decision
  • controlled-randomized study
  • Studies
  • study design
Previous Article
  • Wound treatment

System therapies for dermatological wounds

  • CME continuing education
  • Dermatology and venereology
  • Education
  • Endocrinology and Diabetology
  • General Internal Medicine
  • Geriatrics
  • RX
  • Studies
View Post
Next Article
  • Early Warning Score

Warning signs for chronic pain after surgery

  • Anesthesiology
  • General Internal Medicine
  • Physical medicine and rehabilitation
  • RX
  • Studies
  • Surgery
View Post
You May Also Like
View Post
  • 4 min
  • Case report: Drug-induced hepatitis

Rare side effect of tirzepatide therapy

    • Cases
    • Education
    • Endocrinology and Diabetology
    • Gastroenterology and Hepatology
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 4 min
  • Plea for sex-specific neurology

Migraine in men: underdiagnosed, underestimated, under-researched

    • Education
    • Neurology
    • RX
    • Studies
View Post
  • 4 min
  • Prurigo nodularis

Retrospective analyses of large data sets from everyday practice

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • RX
View Post
  • 3 min
  • Public Health

Outpatient care in Switzerland: situation report

    • General Internal Medicine
    • Practice Management
    • Prevention and health care
    • RX
View Post
  • 5 min
  • Practice Management

Improved quality of care aims for satisfied patients

    • CME continuing education
    • General Internal Medicine
    • Practice Management
    • Prevention and health care
    • RX
    • Studies
View Post
  • 30 min
  • Chemsex - MSM, sex, chrystal meth & co.

Medical and psychosocial perspectives

    • CME continuing education
    • General Internal Medicine
    • Infectiology
    • Pharmacology and toxicology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • RX
View Post
  • 3 min
  • Bladder cancer

Tuberculosis vaccination reduces recurrences

    • Congress Reports
    • Oncology
    • Pneumology
    • Prevention and health care
    • RX
    • Studies
    • Urology
View Post
  • 4 min
  • Oral JAK-i in atopic dermatitis

Benefits and risks: What does the current data say?

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • RX
    • Studies
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
  • Dermatology News

    Zum Thema
Top CME content
  • 1
    Patience, knowledge and persistence in therapy
  • 2
    Sarcopenia and malnutrition in the context of pneumological rehabilitation
  • 3
    Medical and psychosocial perspectives
  • 4
    New nomenclature for non-alcoholic fatty liver disease
  • 5
    Examinations and considerations before therapy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.